{"id":690,"date":"2026-02-28T15:23:21","date_gmt":"2026-02-28T15:23:21","guid":{"rendered":"https:\/\/heartcareforyou.in\/blog\/subcutaneous-icd-definition-clinical-context-and-cardiology-overview\/"},"modified":"2026-02-28T15:23:21","modified_gmt":"2026-02-28T15:23:21","slug":"subcutaneous-icd-definition-clinical-context-and-cardiology-overview","status":"publish","type":"post","link":"https:\/\/heartcareforyou.in\/blog\/subcutaneous-icd-definition-clinical-context-and-cardiology-overview\/","title":{"rendered":"Subcutaneous ICD: Definition, Clinical Context, and Cardiology Overview"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Subcutaneous ICD Introduction (What it is)<\/h2>\n\n\n\n<p>A Subcutaneous ICD is an implantable cardiac device that detects and treats dangerous ventricular arrhythmias.<br\/>\nIt is a type of implantable cardioverter-defibrillator (ICD) designed to sit under the skin rather than inside the heart and veins.<br\/>\nIt is commonly encountered in electrophysiology and heart failure risk management when preventing sudden cardiac death is a goal.<br\/>\nIt is discussed when a patient needs defibrillation therapy but may not need long-term pacing.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Why Subcutaneous ICD matters in cardiology (Clinical relevance)<\/h2>\n\n\n\n<p>Sudden cardiac death most often results from malignant ventricular arrhythmias, especially ventricular tachycardia (VT) and ventricular fibrillation (VF). ICD therapy is a cornerstone preventive strategy in selected patients at elevated risk, because it can recognize these rhythms and deliver a life-saving shock when needed.<\/p>\n\n\n\n<p>A Subcutaneous ICD matters because it provides defibrillation capability without placing a lead inside the heart or transvenous (through-a-vein) system. This anatomic difference can be clinically important in patients where intravascular hardware is less desirable, such as those with limited venous access, higher infection risk, or certain congenital heart anatomies. It also matters educationally: it reinforces how therapy choices in cardiology often hinge on matching device capabilities (defibrillation vs pacing) to patient physiology and arrhythmia mechanisms.<\/p>\n\n\n\n<p>In practice, choosing between a Subcutaneous ICD and a traditional transvenous ICD is less about \u201cbetter vs worse\u201d and more about \u201cfit for the clinical problem.\u201d Learners can use the Subcutaneous ICD as a framework for clinical reasoning: define the arrhythmia risk, define pacing needs, and then select a device that provides the necessary functions with acceptable trade-offs.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Classification \/ types \/ variants<\/h2>\n\n\n\n<p>A Subcutaneous ICD is best understood by comparing it to other ICD system types and by noting common clinical \u201cuse-case\u201d categories.<\/p>\n\n\n\n<p>Key classifications include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>By lead location<\/strong><\/li>\n<li><strong>Subcutaneous ICD<\/strong>: generator in a lateral chest pocket; lead tunneled under the skin along the sternum.<\/li>\n<li>\n<p><strong>Transvenous ICD<\/strong>: lead(s) placed through a vein into the right heart (and sometimes coronary sinus for resynchronization).<\/p>\n<\/li>\n<li>\n<p><strong>By clinical indication category<\/strong><\/p>\n<\/li>\n<li><strong>Primary prevention<\/strong>: implanted to reduce risk of sudden cardiac death before a sustained VT\/VF event has occurred, in selected high-risk conditions.<\/li>\n<li>\n<p><strong>Secondary prevention<\/strong>: implanted after survival of VT\/VF or resuscitated cardiac arrest not due to a clearly reversible cause.<\/p>\n<\/li>\n<li>\n<p><strong>By device capability set (functional \u201cvariants\u201d)<\/strong><\/p>\n<\/li>\n<li><strong>Defibrillation-only focus<\/strong>: Subcutaneous ICDs provide high-energy shocks for VT\/VF detection and termination.<\/li>\n<li><strong>Pacing features<\/strong>: unlike many transvenous ICDs, a Subcutaneous ICD generally does <strong>not<\/strong> provide chronic bradycardia pacing, cardiac resynchronization therapy (CRT), or anti-tachycardia pacing (ATP) for monomorphic VT. Some systems can provide brief post-shock pacing; specifics vary by device design and programming.<\/li>\n<\/ul>\n\n\n\n<p>There are also differences in device generation, sensing algorithms, and programming options across manufacturers and models; details vary by protocol and patient factors.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Relevant anatomy &amp; physiology<\/h2>\n\n\n\n<p>Understanding a Subcutaneous ICD starts with the anatomy of arrhythmia origins and the pathways for sensing and therapy.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Electrical conduction system (arrhythmia substrate)<\/strong><\/li>\n<li>The sinoatrial (SA) node initiates normal rhythm, the atrioventricular (AV) node delays conduction, and the His\u2013Purkinje system distributes impulses through the ventricles.<\/li>\n<li>\n<p>Ventricular arrhythmias often arise from scar-related reentry (e.g., post\u2013myocardial infarction) or from diffuse electrical instability (e.g., cardiomyopathies, channelopathies).<\/p>\n<\/li>\n<li>\n<p><strong>Where the Subcutaneous ICD \u201clives\u201d<\/strong><\/p>\n<\/li>\n<li>The <strong>pulse generator<\/strong> sits in a subcutaneous pocket, commonly on the left lateral chest wall.<\/li>\n<li>\n<p>The <strong>electrode\/lead<\/strong> is tunneled under the skin parallel to the sternum. This positioning creates sensing vectors that capture the heart\u2019s far-field electrical signals (analogous to surface electrocardiogram [ECG] concepts).<\/p>\n<\/li>\n<li>\n<p><strong>How shocks affect the heart<\/strong><\/p>\n<\/li>\n<li>Defibrillation delivers a high-energy electrical shock across the thorax to depolarize a critical mass of myocardial tissue, interrupting VF or unstable VT and allowing organized rhythm to re-emerge.<\/li>\n<li>Successful defibrillation depends on factors such as shock vector relative to the heart, myocardial mass, and electrical properties of tissue; these relationships are physiologic and patient-specific.<\/li>\n<\/ul>\n\n\n\n<p>This anatomy\u2013physiology link is central: the Subcutaneous ICD is outside the vascular system, so it changes infection and access considerations, but it also changes pacing capabilities and sensing challenges.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Pathophysiology or mechanism<\/h2>\n\n\n\n<p>A Subcutaneous ICD is a <strong>therapeutic device<\/strong> designed to prevent sudden arrhythmic death by detecting and terminating malignant ventricular arrhythmias.<\/p>\n\n\n\n<p>Core mechanisms:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Sensing<\/strong><\/li>\n<li>The device continuously senses cardiac electrical activity through subcutaneous electrodes, producing signals that are \u201cfar-field\u201d compared with intracardiac electrograms.<\/li>\n<li>\n<p>It uses programmed algorithms to classify rhythms by features such as rate and morphology. Because sensing is subcutaneous, the system must distinguish true QRS complexes from T-waves and external noise; performance can vary by patient anatomy and ECG characteristics.<\/p>\n<\/li>\n<li>\n<p><strong>Detection and decision-making<\/strong><\/p>\n<\/li>\n<li>When a rhythm meets programmed criteria for VT\/VF, the device charges its capacitor and prepares therapy.<\/li>\n<li>\n<p>Many systems include discrimination features intended to reduce inappropriate shocks from supraventricular tachycardias or oversensing. Exact behavior varies by device and programming.<\/p>\n<\/li>\n<li>\n<p><strong>Therapy delivery<\/strong><\/p>\n<\/li>\n<li>The primary therapy is a <strong>high-energy shock<\/strong> delivered across a subcutaneous shock vector (lead-to-generator configuration).<\/li>\n<li>The goal is to terminate VF or unstable VT by globally depolarizing myocardium. This is not \u201cfixing\u201d the underlying disease substrate; it is interrupting a lethal rhythm when it occurs.<\/li>\n<\/ul>\n\n\n\n<p>Because a Subcutaneous ICD does not typically provide ATP, it may be less suited for patients with frequent monomorphic VT that could otherwise be painlessly terminated by pacing. Device choice therefore connects directly to arrhythmia mechanism and expected rhythm type.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Clinical presentation or indications<\/h2>\n\n\n\n<p>A Subcutaneous ICD is not \u201cpresented\u201d as a symptom; it is chosen in clinical scenarios where defibrillation protection is indicated. Common scenarios include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Secondary prevention<\/strong><\/li>\n<li>\n<p>Survivors of VT\/VF or resuscitated cardiac arrest when a non-reversible cause is suspected or when risk remains elevated.<\/p>\n<\/li>\n<li>\n<p><strong>Primary prevention in selected high-risk conditions<\/strong><\/p>\n<\/li>\n<li>Cardiomyopathies (ischemic or non-ischemic) with elevated arrhythmic risk.<\/li>\n<li>Certain inherited arrhythmia syndromes (channelopathies) where VF risk is a concern.<\/li>\n<li>\n<p>Structural heart disease associated with ventricular arrhythmias.<\/p>\n<\/li>\n<li>\n<p><strong>Situations where avoiding transvenous leads is attractive<\/strong><\/p>\n<\/li>\n<li>Limited or complicated venous access.<\/li>\n<li>Higher concern for intravascular infection (varies by clinician and case).<\/li>\n<li>Younger patients expected to live many years with device hardware.<\/li>\n<li>\n<p>Some congenital heart disease anatomies where intracardiac leads are challenging.<\/p>\n<\/li>\n<li>\n<p><strong>When pacing is not expected to be needed<\/strong><\/p>\n<\/li>\n<li>No current indication for chronic bradycardia pacing, CRT, or ATP.<\/li>\n<\/ul>\n\n\n\n<p>Indications are individualized and depend on underlying diagnosis, arrhythmia history, ECG characteristics, and anticipated pacing needs.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Diagnostic evaluation &amp; interpretation<\/h2>\n\n\n\n<p>Evaluation around a Subcutaneous ICD includes two parallel tasks: (1) confirming that ICD therapy is indicated and (2) confirming that a Subcutaneous ICD is an appropriate <em>type<\/em> of ICD for the patient.<\/p>\n\n\n\n<p>Typical elements include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Arrhythmic risk and underlying diagnosis<\/strong><\/li>\n<li>History of syncope, palpitations, cardiac arrest, family history, and known cardiomyopathy or inherited arrhythmia syndromes.<\/li>\n<li>Baseline ECG to assess conduction abnormalities, repolarization patterns, and rhythm.<\/li>\n<li>Imaging such as echocardiography for ventricular structure and function; cardiac magnetic resonance imaging (MRI) may be used for scar assessment when appropriate and feasible.<\/li>\n<li>\n<p>Additional testing (e.g., ambulatory monitoring, exercise testing, electrophysiology study) varies by protocol and patient factors.<\/p>\n<\/li>\n<li>\n<p><strong>Device selection assessment<\/strong><\/p>\n<\/li>\n<li><strong>Pacing needs assessment<\/strong>: presence of symptomatic bradycardia, high-grade AV block, need for CRT, or anticipated need for ATP shifts consideration toward transvenous systems.<\/li>\n<li>\n<p><strong>Sensing suitability<\/strong>: Subcutaneous ICD candidacy typically includes an ECG-based screening process to reduce the chance of oversensing (e.g., T-wave oversensing). The concept is similar to ensuring the device can reliably recognize QRS complexes across postures and activity states.<\/p>\n<\/li>\n<li>\n<p><strong>Post-implant interpretation and monitoring<\/strong><\/p>\n<\/li>\n<li>Device interrogation reviews sensed signals, detected episodes, therapies delivered, and battery status.<\/li>\n<li>Clinicians interpret whether shocks were appropriate (true VT\/VF) or inappropriate (misclassification\/oversensing), and whether reprogramming or additional therapy is needed.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Management overview (General approach)<\/h2>\n\n\n\n<p>Management involving a Subcutaneous ICD fits into a broader care pathway focused on preventing sudden arrhythmic death while treating the underlying cardiac condition.<\/p>\n\n\n\n<p>High-level approach:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>1) Treat the underlying heart disease<\/strong><\/li>\n<li>Guideline-directed medical therapy for heart failure or cardiomyopathy when indicated.<\/li>\n<li>Management of ischemia, valvular disease, inflammation, or genetic conditions as appropriate.<\/li>\n<li>\n<p>Risk factor modification and rehabilitation planning may be part of comprehensive care; specifics vary by clinician and case.<\/p>\n<\/li>\n<li>\n<p><strong>2) Decide whether ICD therapy is indicated<\/strong><\/p>\n<\/li>\n<li>ICD decisions generally integrate clinical history (e.g., prior VT\/VF), imaging findings, and overall prognosis.<\/li>\n<li>\n<p>Shared decision-making commonly includes discussion of goals of care, expected benefits, and limitations.<\/p>\n<\/li>\n<li>\n<p><strong>3) Choose ICD type: Subcutaneous ICD vs transvenous ICD<\/strong><\/p>\n<\/li>\n<li>A Subcutaneous ICD may be favored when defibrillation is needed and chronic pacing features are not.<\/li>\n<li>\n<p>A transvenous ICD may be favored when bradycardia pacing, CRT, or ATP is expected to be important.<\/p>\n<\/li>\n<li>\n<p><strong>4) Implantation and programming<\/strong><\/p>\n<\/li>\n<li>Implantation is a procedure creating a generator pocket and tunneling a subcutaneous lead.<\/li>\n<li>\n<p>Programming aims to balance rapid treatment of dangerous rhythms with minimizing inappropriate shocks; programming strategies vary by protocol and patient factors.<\/p>\n<\/li>\n<li>\n<p><strong>5) Follow-up and longitudinal care<\/strong><\/p>\n<\/li>\n<li>Wound checks, device interrogations, and remote monitoring (when available) help detect lead issues, sensing problems, or arrhythmia recurrence.<\/li>\n<li>Additional therapies (antiarrhythmic drugs, catheter ablation) may be used to reduce arrhythmia burden and shocks, depending on the clinical scenario.<\/li>\n<\/ul>\n\n\n\n<p>This is educational information only; individualized management decisions require clinician evaluation.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Complications, risks, or limitations<\/h2>\n\n\n\n<p>Complications and limitations depend on patient factors, implant technique, and device programming. Commonly discussed issues include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Procedure-related and pocket-related<\/strong><\/li>\n<li>Pain, swelling, hematoma, or seroma at the generator pocket.<\/li>\n<li>Wound healing problems, skin erosion, or cosmetic concerns.<\/li>\n<li>\n<p>Infection; while intravascular infection is a key concern with transvenous leads, subcutaneous systems can still develop pocket infections.<\/p>\n<\/li>\n<li>\n<p><strong>Lead and system issues<\/strong><\/p>\n<\/li>\n<li>Lead migration, discomfort along the lead track, or mechanical problems.<\/li>\n<li>\n<p>Sensing challenges due to far-field signals, including <strong>T-wave oversensing<\/strong> or myopotential (muscle) noise, which can contribute to inappropriate therapy.<\/p>\n<\/li>\n<li>\n<p><strong>Therapy-related<\/strong><\/p>\n<\/li>\n<li><strong>Inappropriate shocks<\/strong> (e.g., oversensing or rhythm misclassification).<\/li>\n<li>\n<p>Failure to terminate an arrhythmia or delayed therapy (uncommon but clinically important when it occurs); defibrillation efficacy can be influenced by anatomy and shock vector.<\/p>\n<\/li>\n<li>\n<p><strong>Capability limitations<\/strong><\/p>\n<\/li>\n<li>Lack of chronic bradycardia pacing support.<\/li>\n<li>Lack of ATP for terminating some forms of monomorphic VT without shocks.<\/li>\n<li>\n<p>Not designed to provide CRT for dyssynchrony-related heart failure.<\/p>\n<\/li>\n<li>\n<p><strong>Other considerations<\/strong><\/p>\n<\/li>\n<li>Interactions with other implanted devices can be relevant; compatibility considerations vary by device models and clinical context.<\/li>\n<li>Imaging and procedural planning (including MRI) depend on device labeling and institutional protocols.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Prognosis &amp; follow-up considerations<\/h2>\n\n\n\n<p>A Subcutaneous ICD is intended to improve outcomes by preventing death from treatable ventricular tachyarrhythmias. Overall prognosis, however, is driven by the underlying cardiac condition (e.g., cardiomyopathy severity, ischemic burden, genetic syndrome characteristics), comorbidities, and the frequency and type of arrhythmias.<\/p>\n\n\n\n<p>Follow-up commonly focuses on:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Assessing device performance<\/strong><\/li>\n<li>Regular interrogation to review sensing integrity, detected episodes, and any delivered shocks.<\/li>\n<li>\n<p>Evaluating for inappropriate detections and considering reprogramming when indicated (varies by clinician and case).<\/p>\n<\/li>\n<li>\n<p><strong>Assessing the patient\u2019s clinical trajectory<\/strong><\/p>\n<\/li>\n<li>Monitoring heart failure status, ischemia symptoms, syncope, and medication tolerance.<\/li>\n<li>\n<p>Reviewing whether new pacing needs have emerged over time (e.g., progressive conduction disease), which can affect long-term device strategy.<\/p>\n<\/li>\n<li>\n<p><strong>Reducing shock burden<\/strong><\/p>\n<\/li>\n<li>\n<p>Shocks can be physically and psychologically distressing. Clinicians often aim to reduce avoidable shocks by optimizing programming and addressing arrhythmia triggers or substrate through medications or ablation when appropriate.<\/p>\n<\/li>\n<li>\n<p><strong>Lifestyle and activity counseling<\/strong><\/p>\n<\/li>\n<li>Return to activity, work, and sports is individualized based on underlying diagnosis, arrhythmia history, and procedural recovery. Recommendations vary by protocol and patient factors.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Subcutaneous ICD Common questions (FAQ)<\/h2>\n\n\n\n<p><strong>Q: What does \u201cSubcutaneous ICD\u201d mean in plain language?<\/strong><br\/>\nIt means an implantable defibrillator placed under the skin rather than inside the heart and veins. The device monitors heart rhythm and can deliver a shock if a dangerous ventricular rhythm is detected. It is one way to provide protection against sudden cardiac death in selected patients.<\/p>\n\n\n\n<p><strong>Q: Is a Subcutaneous ICD the same as a pacemaker?<\/strong><br\/>\nNo. A pacemaker primarily treats slow heart rhythms by delivering small pacing impulses. A Subcutaneous ICD is primarily designed to treat fast, life-threatening ventricular arrhythmias with a defibrillation shock; it generally does not provide ongoing pacing support like many pacemakers do.<\/p>\n\n\n\n<p><strong>Q: What heart rhythms does a Subcutaneous ICD treat?<\/strong><br\/>\nIt is intended to detect and terminate ventricular tachycardia (VT) and ventricular fibrillation (VF) when they meet programmed criteria. It is not designed to treat atrial fibrillation or other supraventricular tachycardias directly, although those rhythms can sometimes be misclassified depending on sensing and programming.<\/p>\n\n\n\n<p><strong>Q: Who might be considered for a Subcutaneous ICD instead of a transvenous ICD?<\/strong><br\/>\nPatients who need defibrillation protection but do not need chronic pacing or anti-tachycardia pacing may be considered. It can also be considered when avoiding intravascular leads is desirable, such as in some patients with limited venous access or higher infection concern. Final selection varies by clinician and case.<\/p>\n\n\n\n<p><strong>Q: How is a Subcutaneous ICD implanted?<\/strong><br\/>\nA generator is placed in a subcutaneous pocket on the chest wall, and a lead is tunneled under the skin along the breastbone area. Because the system is subcutaneous, no leads are placed inside the heart chambers through veins. Procedural details depend on the center\u2019s technique and patient anatomy.<\/p>\n\n\n\n<p><strong>Q: What does it feel like if the device delivers a shock?<\/strong><br\/>\nPatients often describe ICD shocks as sudden and intense. The exact experience varies with the person, the rhythm being treated, and the circumstances. Clinicians also pay attention to shock frequency because recurrent shocks can affect quality of life.<\/p>\n\n\n\n<p><strong>Q: Can a Subcutaneous ICD deliver pacing to stop ventricular tachycardia without a shock?<\/strong><br\/>\nTypically, no. Many transvenous ICDs can deliver anti-tachycardia pacing (ATP) for certain monomorphic VT episodes, which may terminate the rhythm without a shock. A Subcutaneous ICD generally relies on shock therapy for terminating VT\/VF.<\/p>\n\n\n\n<p><strong>Q: How do clinicians check if the Subcutaneous ICD is working properly?<\/strong><br\/>\nThey use device interrogation to review sensing signals, detected arrhythmia episodes, and delivered therapies, and to assess battery and system integrity. Many patients also use remote monitoring systems, depending on device features and clinic workflow. Follow-up intervals vary by protocol and patient factors.<\/p>\n\n\n\n<p><strong>Q: Will I be able to return to normal activities after implantation?<\/strong><br\/>\nMany people resume usual activities over time, but timing and restrictions depend on wound healing, underlying heart disease, and any arrhythmia events. Activity guidance often includes short-term precautions related to the implant site and longer-term considerations related to the condition that prompted ICD placement. Recommendations vary by clinician and case.<\/p>\n\n\n\n<p><strong>Q: What are common reasons a Subcutaneous ICD might deliver an inappropriate shock?<\/strong><br\/>\nInappropriate shocks can occur if the device oversenses signals (such as T-waves or muscle noise) or misclassifies a fast non-ventricular rhythm. ECG-based screening and careful programming aim to reduce this risk, but it cannot be eliminated. If inappropriate shocks occur, clinicians typically reassess sensing vectors, programming, and contributing rhythm issues.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Subcutaneous ICD is an implantable cardiac device that detects and treats dangerous ventricular arrhythmias. It is a type of implantable cardioverter-defibrillator (ICD) designed to sit under the skin rather than inside the heart and veins. It is commonly encountered in electrophysiology and heart failure risk management when preventing sudden cardiac death is a goal. It is discussed when a patient needs defibrillation therapy but may not need long-term pacing.<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-690","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts\/690","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/comments?post=690"}],"version-history":[{"count":0,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts\/690\/revisions"}],"wp:attachment":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/media?parent=690"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/categories?post=690"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/tags?post=690"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}